首页> 外文期刊>Acta Pharmaceutica Sinica B >Synchronous conjugation of i-motif DNA and therapeutic siRNA on the vertexes of tetrahedral DNA nanocages for efficient gene silence
【24h】

Synchronous conjugation of i-motif DNA and therapeutic siRNA on the vertexes of tetrahedral DNA nanocages for efficient gene silence

机译:I-MOTIF DNA和治疗siRNA对四面体DNA纳米骨顶部有效基因沉默的同步缀合

获取原文
           

摘要

The functionality of DNA biomacromolecules has been widely excavated, as therapeutic drugs, carriers, and functionalized modification derivatives. In this study, we developed a series of DNA tetrahedron nanocages (Td), via synchronous conjugating different numbers of i-(X) and therapeutic siRNA on four vertexes of tetrahedral DNA nanocage ( [email?protected] , a + b =?4). This i-motif-conjugated Td exhibited good endosomal escape behaviours in A549 tumor cells, and the escape efficiency was affected by the number of i-motif. Furthermore, the downregulating mRNA and protein expression level of epidermal growth factor receptor (EGFR) caused by this siRNA embedded Td were verified in A549?cells. The tumor growth inhibition efficiency of the [email?protected] treated group in tumor-bearing mice was significantly higher than that of non-i-motif-conjugated [email?protected] (3.14-fold) and free siRNA (3.63-fold). These results demonstrate a general strategy for endowing DNA nanostructures with endosomal escape behaviours to achieve effective in?vivo gene delivery and therapy.
机译:DNA生物致摩洛族的功能已被广泛挖掘,作为治疗药物,载体和官能化改性衍生物。在这项研究中,我们开发了一系列DNA四面体纳米病(TD),通过同步缀合不同数量的I-(X)和治疗siRNA在四面体DNA纳米的四个顶点上([电子邮件吗?保护),A + B =?4 )。该I-MOTIF-CONCORICTATIONTTD在A549肿瘤细胞中表现出良好的内体逃生行为,逃逸效率受I-MOTIF数量的影响。此外,由该siRNA嵌入式Td引起的表皮生长因子受体(EGFR)的下降mRNA和蛋白表达水平在A549中验证了细胞。肿瘤瘤小鼠的[邮件吗?受保护的]治疗组的肿瘤生长抑制效率显着高于非I-MOTIF-CONGUINGED的[email?porpered](3.14倍)和游离siRNA(3.63倍) 。这些结果表明了一种赋予DNA纳米结构的一般策略,所述DNA纳米结构具有内体逃逸行为,以实现有效的?体内基因递送和治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号